Alkeran 50mg powder and solvent for solution for injection vials Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

alkeran 50mg powder and solvent for solution for injection vials

aspen pharma trading ltd - melphalan hydrochloride - powder and solvent for solution for injection - 50mg

Melphalan medac 50 mg powder and solvent for solution for injection/infusion Irsko - angličtina - HPRA (Health Products Regulatory Authority)

melphalan medac 50 mg powder and solvent for solution for injection/infusion

medac gesellschaft für klinische spezialpräparate mbh - melphalan - powder and solvent for solution for injection/infusion - 50 milligram(s) - melphalan

Melphalan Tillomed 50 mg inj./inf. sol. (pwdr. + solv.) i.v./i.arter. vial Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

melphalan tillomed 50 mg inj./inf. sol. (pwdr. + solv.) i.v./i.arter. vial

tillomed pharma gmbh - melperone hydrochloride 55,973 mg - eq. melphalan 50 mg - powder and solvent for solution for injection/infusion - 50 mg - melperone hydrochloride 55.973 mg - melphalan

ALKERAN- melphalan tablet, film coated Spojené státy - angličtina - NLM (National Library of Medicine)

alkeran- melphalan tablet, film coated

apopharma usa, inc. - melphalan (unii: q41or9510p) (melphalan - unii:q41or9510p) - melphalan 2 mg - alkeran tablets are indicated for the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary. alkeran should not be used in patients whose disease has demonstrated a prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.

APO-MELPHALAN melphalan (as hydrochloride) 50 mg powder for injection glass vial with diluent Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

apo-melphalan melphalan (as hydrochloride) 50 mg powder for injection glass vial with diluent

arrotex pharmaceuticals pty ltd - melphalan hydrochloride, quantity: 55.97 mg (equivalent: melphalan, qty 50 mg) - injection, powder for - excipient ingredients: povidone; hydrochloric acid - melphalan injection is indicated for the treatment of patients with multiple myeloma for whom oral therapy is not appropriate.

ALKERAN SOLUTION Kanada - angličtina - Health Canada

alkeran solution

aspen pharmacare canada inc. - melphalan (melphalan hydrochloride); buffer solution - solution - 50mg; 10ml - melphalan (melphalan hydrochloride) 50mg; buffer solution 10ml - antineoplastic agents

Melphalan Pharmexon 50 mg powder and solvent for solution for injection/infusion Irsko - angličtina - HPRA (Health Products Regulatory Authority)

melphalan pharmexon 50 mg powder and solvent for solution for injection/infusion

pharmexon consulting s.r.o - melphalan hydrocholoride - powder and solvent for solution for injection/infusion - 50 milligram(s) - nitrogen mustard analogues; melphalan

Melphalan Tillomed 50 mg powder and solvent for solution for injection/infusion Irsko - angličtina - HPRA (Health Products Regulatory Authority)

melphalan tillomed 50 mg powder and solvent for solution for injection/infusion

tillomed pharma gmbh - melphalan hydrochloride - powder and solvent for solution for injection/infusion - 50 milligram(s) - nitrogen mustard analogues; melphalan

MELPHALAN HYDROCHLORIDE kit Spojené státy - angličtina - NLM (National Library of Medicine)

melphalan hydrochloride kit

athenex pharmaceutical division, llc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.

MELPHALAN HYDROCHLORIDE kit Spojené státy - angličtina - NLM (National Library of Medicine)

melphalan hydrochloride kit

avenacy inc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.